OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

(D620N) VPS35 causes the impairment of Wnt/β-catenin signaling cascade and mitochondrial dysfunction in a PARK17 knockin mouse model
Ching‐Chi Chiu, Yi-Hsin Weng, Ying‐Zu Huang, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
Jiaqi Liu, Qing Xiao, Jiani Xiao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 1269

The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?
Adina N. MacMahon Copas, Sarah F. McComish, Jean M. Fletcher, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 129

Mitochondrial-derived vesicles in metabolism, disease, and aging
Tim König, Heidi M. McBride
Cell Metabolism (2024) Vol. 36, Iss. 1, pp. 21-35
Open Access | Times Cited: 49

Targeting mitophagy in neurodegenerative diseases
Odetta Antico, Paul Thompson, Nicholas T. Hertz, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 11

Mitochondrial Complex I as a Pathologic and Therapeutic Target for Parkinson’s Disease
Kamatham Pushpa Tryphena, Uppala Sai Nikhil, Poojitha Pinjala, et al.
ACS Chemical Neuroscience (2023)
Closed Access | Times Cited: 26

Understanding the contributions of VPS35 and the retromer in neurodegenerative disease
Erin T. Williams, Xi Chen, P. Anthony Otero, et al.
Neurobiology of Disease (2022) Vol. 170, pp. 105768-105768
Open Access | Times Cited: 33

VPS35 and retromer dysfunction in Parkinson's disease
Jordan Rowlands, Darren J. Moore
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 6

Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson’s Disease
Shayesteh Kokabi Hamidpour, Mobina Amiri, Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 6

Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies
Dmytro Morderer, Melissa C. Wren, Feilin Liu, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access

Deficiency of RAB39B Activates ER Stress-Induced Pro-apoptotic Pathway and Causes Mitochondrial Dysfunction and Oxidative Stress in Dopaminergic Neurons by Impairing Autophagy and Upregulating α-Synuclein
Ching‐Chi Chiu, Yi-Hsin Weng, Tu‐Hsueh Yeh, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 5, pp. 2706-2728
Closed Access | Times Cited: 9

miR-15b-5p transcription mediated by CREB1 protects against inflammation and apoptosis in Parkinson disease models by inhibiting AXIN2 and activating Wnt/β-catenin
Tianyi Liu, Guozhong Li
Journal of Neuropathology & Experimental Neurology (2023) Vol. 82, Iss. 12, pp. 995-1009
Closed Access | Times Cited: 7

A novel autophagy-related genes prognostic risk model and validation of autophagy-related oncogene VPS35 in breast cancer
Xiaoying Li, Yu Cao, Xinmiao Yu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 15

VPS35 promotes gastric cancer progression through integrin/FAK/SRC signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent manner
Qingqing Zhou, Qi Feng, Chenfei Zhou, et al.
Oncogene (2023) Vol. 43, Iss. 2, pp. 106-122
Open Access | Times Cited: 6

Mechanisms of VPS35-mediated neurodegeneration in Parkinson's disease
Dorian Sargent, Darren J. Moore
International review of movement disorders (2021), pp. 221-244
Open Access | Times Cited: 14

Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyond
Rachael J. Chandler, Susanna Cogo, Patrick A. Lewis, et al.
Bioscience Reports (2021) Vol. 41, Iss. 9
Open Access | Times Cited: 11

4-Oxo-2-nonenal-Induced α-Synuclein Oligomers Interact with Membranes in the Cell, Leading to Mitochondrial Fragmentation
Camilla Andersen, Astrid Komal Lausdahl, Janni Nielsen, et al.
Biochemistry (2023) Vol. 62, Iss. 16, pp. 2417-2425
Open Access | Times Cited: 4

Multifaceted roles of mitochondrial dysfunction in diseases: from powerhouses to saboteurs
Surapriya Surendranath Prabhu, Aathira Sujathan Nair, Saiprabha Vijayakumar Nirmala
Archives of Pharmacal Research (2023) Vol. 46, Iss. 9-10, pp. 723-743
Closed Access | Times Cited: 4

VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progress
Anika Wu, Daehoon Lee, Wen-Cheng Xiong
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 8, pp. 701-712
Open Access | Times Cited: 1

Parkinson's in the bone
Lei Xiong, Jin‐Xiu Pan, Hao-Han Guo, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 9

Deliver on Time or Pay the Fine: Scheduling in Membrane Trafficking
Giampaolo Placidi, Carlo Cosimo Campa
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11773-11773
Open Access | Times Cited: 6

Beware of Misdelivery: Multifaceted Role of Retromer Transport in Neurodegenerative Diseases
Shun Yoshida, Takafumi Hasegawa
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 4

Retromer dependent changes in cellular homeostasis and Parkinson's disease
Zhe Yang, Zebin Li, Rohan D. Teasdale
Essays in Biochemistry (2021) Vol. 65, Iss. 7, pp. 987-998
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top